Cargando…
Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report
BACKGROUND: To our knowledge, no studies have evaluated the safety of carboplatin (CBDCA)-based chemotherapy in hemodialysis patients > 80 years-old. In addition, the impact of CBDCA-based chemotherapy on such elderly patients’ quality of life (QOL) is unknown. We report a case of gemcitabine plu...
Autores principales: | Kondo, Masahiro, Naiki, Taku, Hotta, Yuji, Yamamoto, Yuko, Sugiyama, Yosuke, Yasui, Takahiro, Kimura, Kazunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264041/ https://www.ncbi.nlm.nih.gov/pubmed/30519478 http://dx.doi.org/10.1186/s40780-018-0124-0 |
Ejemplares similares
-
Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Carboplatin After Switching from Cisplatin in a Metastatic Urethral Cancer Patient
por: Sugiyama, Yosuke, et al.
Publicado: (2017) -
A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review
por: Iida, Keitaro, et al.
Publicado: (2015) -
Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) plus Bevacizumab Chemotherapy
por: Naiki, Taku, et al.
Publicado: (2017) -
A pilot study of gemcitabine and paclitaxel as third-line chemotherapy in
metastatic urothelial carcinoma
por: Naiki, Taku, et al.
Publicado: (2017) -
Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis
por: Naiki, Taku, et al.
Publicado: (2018)